Pulse Biosciences Inc (6L8)
XDUS
Real-time Data
06:00 AM
Day's Range
42.8052 wk Range
10.90Overview - 6L8 - Pulse Biosciences Inc
Key Statistics
Valuation
Enterprise Value
-73.20M
P/E (Trailing)
‪-40.00‬
PEG Ratio
‪-1.40‬
Price / Book
‪30.04‬
EV / EBITDA
‪0.96‬
Profitability
Gross Margin
‪37.09%‬
Profit Margin
‪-54.00%‬
Operating Margin
‪-21,982.57%‬
Return on Assets
‪-76.98%‬
Return on Equity
‪-90.23%‬
Ownership
Shares Outstanding
70.79M
Price stats
50-Day Avg
‪40.67‬
200-Day Avg
‪24.05‬
Peers - 6L8 - Pulse Biosciences Inc
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on XDUS.
- 6L8XDUSPulse Biosciences Inc+60.65%52-week change-40.00P/E (Trailing)‪-54.00%‬Profit Margin
- A5IXDUSAtriCure Inc.+38.94%52-week change258.89P/E (Trailing)‪1.85%‬Profit Margin
- 5FRXDUSMenicon Co., Ltd.+37.06%52-week change0.15P/E (Trailing)‪53.81%‬Profit Margin
- RGNXDUSRepligen Corporation+35.69%52-week change189.31P/E (Trailing)‪52.31%‬Profit Margin
- UG2XDUSAngioDynamics Inc.+33.08%52-week change-15.11P/E (Trailing)‪54.62%‬Profit Margin
- BJX1XDUSBioLife Solutions Inc.+32.73%52-week change-366.67P/E (Trailing)‪64.56%‬Profit Margin
- WPSXDUSWest Pharmaceutical Services Inc.+32.06%52-week change47.45P/E (Trailing)‪35.91%‬Profit Margin
Profile Summary - 6L8 - Pulse Biosciences Inc
About
Pulse Biosciences Inc is a bioelectric medicine company focused on developing and commercializing medical technologies that use proprietary pulsed-field energy to treat targeted cells while preserving surrounding tissue. Its current product portfolio includes the nPulse System for benign skin lesions, the nPulse…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
